No Data
Those Who Invested in Amgen (NASDAQ:AMGN) Three Years Ago Are up 34%
Weekly Buzz: Tech stocks hit high scores on ominous day
Dow's 112-Point Fall Led By Losses In NVIDIA Corp., Amgen Shares
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Express News | "Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News
Market Mixed on Friday the 13th | Livestock